‘s stock had its “buy” rating reaffirmed by analysts at Needham & Company LLC in a research note issued on Thursday. They presently have a $28.00 target price on the stock.

Several other analysts have also weighed in on the company. Canaccord Genuity reaffirmed a “hold” rating and issued a $24.00 price objective on shares of HealthStream in a research note on Tuesday.